CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-10-15 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2014-10-15 | Haqq Christopher Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2014-10-15 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 71 of 71 · 1,403 trades